Navigation Links
DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
Date:8/9/2013

Chicago, IL (PRWEB) August 09, 2013

The prescription drug resource center DrugRisk.com is announcing updated information for patients taking the blood thinner Pradaxa. A federal court overseeing more than 1,000 lawsuits alleging the drug caused internal bleeding recently denied an attempt by the maker of the drug to dismiss a case*.

DrugRisk provides patients taking popular prescription drugs with the latest warnings, recalls, studies and legal news to improve safety and awareness. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding. The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**.

Others, like the Institute for Safe Medication Practices, have warned that patients may be nearly 5 times as likely to die from bleeding with Pradaxa than that from warfarin***. DrugRisk has also added a recent study from the Netherlands which suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

So far, more than 1,133 patients have filed a Pradaxa lawsuit alleging internal bleeding, with cases now consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugRisk has learned that Judge David Herndon, who is overseeing the cases, recently blocked attempts by drug maker Boehringer Ingelheim to dismiss a case in which a man alleges Pradaxa caused him internal bleeding injury*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisk.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
*****Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-bleeding/litigation-news/prweb11012356.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
2. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
3. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
4. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
5. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
6. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
7. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
8. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
9. DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
10. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
11. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
Breaking Medicine Technology: